Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Sainsbury’s can ensure focus on its winning food strategy as it sells the Argos fascia, says GlobalData

Following the news that Sainsbury’s will sell Argos to Swift Partners, a new company backed by grocery veterans Richard Pennycook, Trevor Strain and Matt Truman alongside True Capital: Eleanor Simpson-Gould, Senior Retail Analyst at GlobalData, a leading intelligence and productivity, offers her view:   “The sale of Argos is the logical next step in Sainsbury’s food-first strategy. Argos has […]
Read more

Energy companies need to invest in cybersecurity to prevent supply risks, says GlobalData

Energy infrastructure is a high-value target for cybercriminals. Attacks on critical national infrastructure (CNI) can have an outsized impact, disrupting essential services, causing nationwide instability, and generating financial gains for hackers. As geopolitical uncertainty intensifies, so does cyber espionage, making it crucial for energy companies to invest in resilient cybersecurity programs, says GlobalData, a leading […]
Read more

European drug manufacturers under threat from proposed US supply chain bill, says GlobalData

US efforts to scrutinize overseas pharmaceutical manufacturing could expose Europe’s dominant role in supplying FDA-approved innovator and biosimilar drugs, reshaping global biopharma supply chains. Analysis indicates Germany faces the greatest commercial risk as Washington pursues onshoring policies that may trigger tariff and non-tariff measures, creating fresh investment, manufacturing, and market access challenges for pharmaceutical companies […]
Read more

Cell and gene therapy manufacturers turn to specialist automation partners, says GlobalData

Cell and gene therapy manufacturers are partnering with specialist technology companies to address the challenges associated with scaling complex therapies. Recent collaborations between developers, contract development and manufacturing organizations (CDMOs), and automation companies demonstrate how robotics, digital systems, and advanced manufacturing platforms are being integrated into production workflows to support more scalable and efficient manufacturing, […]
Read more

Supply chain insurance seen as must-have protection amid global instability, finds GlobalData

Businesses overwhelmingly view the fallout of geopolitical tensions through the lens of indirect operational disruption, seeking products that safeguard daily commercial operations. Against this backdrop, supply chain insurance is seen as a must-have protection, according to GlobalData, a leading intelligence and productivity platform. According to a poll* conducted by GlobalData on Verdict Media sites in […]
Read more

UK garden retailers must look beyond the spring peak to grow demand, says GlobalData

Garden retailers are missing an opportunity to drive year-round demand by concentrating promotional activity around the spring peak, when consumer purchasing is already at its strongest, according to GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “UK Retail Hot Topics: Gardening 2026,” reveals that 70.9% of consumers begin purchasing gardening products between March […]
Read more

GlobalData Healthcare intelligence now available directly inside Claude through Model Context Protocol (MCP)

LONDON, 30 July 2026: GlobalData Healthcare, the pharmaceutical and life sciences intelligence arm of GlobalData Plc, today announced that its proprietary intelligence datasets are now accessible directly inside Claude, Anthropic’s AI assistant, ChatGPT and Gemini, through GlobalData’s Data MCP. Integrations with Microsoft Copilot and Perplexity follow as part of the same rollout, giving pharma, biotech […]
Read more

FDA regenerative medicine approvals gain momentum, reveals GlobalData

Following several years of limited activity, FDA approvals for regenerative medicines have accelerated, culminating in a record eight approvals in 2024. Recent findings also highlight a surge in regenerative medicine advanced therapy (RMAT) designations, which, together with a robust late-stage pipeline, suggests that FDA approval activity for regenerative medicine products is likely to remain elevated […]
Read more

Niktimvo approval in Australia reinforces momentum for macrophage-targeted cGVHD therapies, says GlobalData

Australia’s Therapeutic Goods Administration (TGA) approved Niktimvo (axatilimab) for chronic graft-versus-host disease (cGVHD) in May 2026, making Australia the first market outside the US to authorize the therapy. The decision strengthens the role of macrophage-targeted treatments for heavily pretreated patients, while highlighting reimbursement, real-world adoption, and earlier-line evidence as key factors shaping its long-term clinical […]
Read more

Underwriting remains top AI use case for insurers as enterprise-wide adoption accelerates, reveals GlobalData

Artificial intelligence (AI) is expanding its role across the insurance value chain as insurers increasingly move beyond its traditional use in underwriting. Growing confidence in AI is driving adoption in product development, customer service, claims management, and other core functions, reflecting a broader shift from isolated use cases towards enterprise-wide transformation aimed at improving efficiency, […]
Read more

Dimerix’s DMX-652 acquisition to bolster kidney disease therapy development, says GlobalData

Dimerix recently announced the acquisition of DMX-652 from Mission Therapeutics, adding a Phase II-ready acute kidney injury (AKI) program with a differentiated mechanism. The acquisition expands Dimerix beyond its late-stage focal segmental glomerulosclerosis (FSGS) asset. The company already has a late-stage rare kidney disease asset in FSGS, so adding DMX-652 creates a continuum from acute […]
Read more

Specialty coffee brews a mainstream opportunity across retail, foodservice and packaging, says GlobalData

Speciality coffee, a fast-growing segment within premium beverages, is gaining prominence across retail, foodservice, and packaging space, evolving from an artisanal niche into a mainstream lifestyle-led category. This is driven by converging consumer demand for premium quality, personalization, functional wellness, ethical sourcing, and sustainable packaging. Brands are increasingly using specialty coffee, which is defined single-origin […]
Read more

MASH market growth in India hinges on awareness-led strategies, says GlobalData

Non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) market in India is entering a new phase, with awareness-driven strategies expected to play a pivotal role in improving diagnosis, treatment access, and patient outcomes. The expanded approval of semaglutide for adults with MASH and fibrosis stages F2–F3 marks a significant development, while rising diagnosed prevalence and growing awareness initiatives […]
Read more

China’s biotech rise to face challenges from US policy responses, says GlobalData

China is emerging as a global biotechnology innovation hub, but its growing influence is facing political and regulatory scrutiny from the US. The US policy response reflects concerns around its competitiveness and technological leadership, rather than the country’s scientific capability alone, says GlobalData, a leading intelligence and productivity platform. China’s scientific progress was on display […]
Read more

Spain insulin pumps market to grow at 8% CAGR through 2036, forecasts GlobalData

Spain’s insulin pumps market is expected to witness steady growth, driven by the increasing prevalence of type 1 diabetes, growing adoption of advanced diabetes management technologies, and rising demand for automated insulin delivery systems. The shift toward personalized, data-driven diabetes care, supported by continuous glucose monitoring (CGM) integration and smart insulin delivery technologies, is accelerating […]
Read more

Global battery energy storage installed capacity to rise sixfold by 2030, forecasts GlobalData

The global battery energy storage system (BESS) capacity is expected to continue to rise to manage growing demand from electrification, industry, and AI/data centers. Moreover, higher proportion of wind and solar increases intra-day variability, imbalance, and curtailment that batteries can mitigate economically. BESS additions are also driven by declining lithium-ion costs, stronger supply chains, and […]
Read more
1 2 3 … 774